Unlike clinical depression or generalized anxiety, diabetes distress is a condition-specific phenomenon: a predictable, near-constant response to the relentless cognitive, emotional and logistical demands of keeping a failing pancreas artificially alive. Researchers have long known that this distress is common among adults with type 1 diabetes and is linked to worse self-management, poorer glycemic outcomes and reduced quality of life. What has remained murky is how that distress is actually experienced at different stages of adult life—a gap the new study set out to close by listening directly to patients rather than measuring them with questionnaires.

The research team, led by investigators at the Albert Einstein College of Medicine and Montefiore Medical Center in the Bronx, used a user-centered design approach, a methodology borrowed from product development that treats patients as genuine stakeholders rather than passive subjects. Nineteen adults with type 1 diabetes took part in six virtual workshops, each lasting about 90 minutes and facilitated by a clinical psychologist. Four sessions were devoted to young adults aged 18 to 34, whose mean age was 23.8 years, and two sessions gathered adults aged 35 to 64. The younger group was notably diverse, with nearly 43 percent identifying as Hispanic or Latino and another 43 percent as Black or African American, while the older group comprised five women recruited through a national patient advocacy council. Sessions were audio-recorded, professionally transcribed and analyzed with an inductive coding process in NVivo, with two analysts independently developing the framework and an audit trail maintained throughout to document every analytic decision.

The first and perhaps most striking finding is how much the two age groups share. Participants across the board identified competing daily priorities as a central driver of distress, alongside the financial and insurance-related friction of obtaining supplies and medications. The burden, participants stressed, was not merely economic. Navigating prior authorizations, recurring administrative hurdles and coverage disputes exacted its own emotional toll. Interpersonal strain surfaced in both groups as well—professional relationships, friendships and family dynamics all reshaped by the visibility of the disease, the sense of being misunderstood, and the exhausting need to repeatedly explain or justify diabetes-related needs. Encounters with the healthcare system emerged as another shared sore point, with participants describing feelings of judgment, frustration and a sense that their emotional well-being was treated as an afterthought to glucose metrics.

Where the groups diverged was in the temporal framing of their suffering. Young adults described distress as immediate and intrusive, a constant background presence that shaped everyday decisions and interfered with the developmental work of establishing independence and identity. Rather than a series of discrete tasks, diabetes was portrayed as an uninvited companion at work, in school and in social settings. Participants admitted to silencing alarms, delaying treatment or hiding their care during meetings to avoid disruption or unwanted attention. Technology figured prominently in this age group’s distress: device malfunctions, alarm fatigue and the sheer visibility of continuous glucose monitors and pumps contributed to feelings of stigma and of being marked as different from peers, sometimes pushing participants toward disengagement from self-care altogether.

Adults aged 35 to 64 told a strikingly different story. For them, distress was cumulative and future-oriented, shaped by decades of unbroken disease management, the accumulation of co-existing medical conditions and mounting anxieties about sustaining care into retirement. Many reflected on how their distress had evolved over the years, with self-management increasingly intertwined with family responsibilities, caregiving demands and long-term financial planning. The fear of complications and the physical wear and tear of long-standing diabetes loomed large. Clinical visits were frequently described as judgment-laden experiences—one participant compared meeting with the endocrinologist to sitting in the principal’s office—while the financial arithmetic of survival was expressed with bleak candor: the amount spent to stay alive, one participant noted, could have bought a house.

Across both groups, participants consistently distinguished diabetes distress from depression and anxiety, framing it instead as an expected reaction to a complex, lifelong condition. One participant captured the pervasiveness of the phenomenon by observing that almost everything a person with type 1 diabetes goes through has the potential to cause distress, from difficulty obtaining supplies to navigating insurance requirements to accessing timely care. The cognitive load was a recurring motif: young adults spoke of working hard simply to stay alive, while older participants tallied the extra hundreds of decisions the disease forces into each day. Taken together, the narratives suggest that diabetes distress arises not from any isolated task but from the cumulative challenge of integrating relentless disease management into the competing demands of ordinary life.

The study’s findings carry direct consequences for how psychological interventions are built. Core strategies—emotional validation, cognitive restructuring and problem-solving—appear broadly relevant across age groups, but the researchers argue that content and emphasis should be tuned to life-stage-specific stressors. The workshops directly informed the refinement of the Reduce intervention, a cognitive-behavioral program being developed within two ongoing randomized controlled trials. For young adults, that means addressing technology fatigue, competing priorities and identity-related concerns; for the older group, it means emphasizing cumulative burden, caregiving responsibilities and long-term planning. The authors also flag implications for routine clinical screening, suggesting that standard questionnaires may underestimate distress when they focus narrowly on emotional symptoms while ignoring contextual stressors such as cost, caregiving or technology burden. Brief, open-ended questions in routine encounters, paired with clinician training in empathetic, non-punitive communication, could improve detection of distress that is situational, cumulative or anticipatory in nature.

There are limits worth noting. The sample was small, workshop sizes shrank below their intended scale because of scheduling constraints, and every participant in the 35-to-64 group was female, which may constrain transferability to men of the same age. No validated distress instrument was administered, so severity cannot be benchmarked against established clinical thresholds, and recruitment from clinics and advocacy organizations likely captured people already engaged in care. Older adults aged 65 and beyond were outside the study’s scope and remain an important frontier, as aging with type 1 diabetes introduces clinical and psychosocial challenges of its own. Future work, the authors suggest, should examine distress longitudinally, stratify analyses by age and disease duration, and include more racially, ethnically and socioeconomically diverse populations, given well-documented disparities in outcomes and access.

What the study ultimately delivers is a conceptual upgrade: diabetes distress, long treated as a static psychological state, emerges instead as a dynamic, developmental and profoundly systemic experience—one shaped as much by insurance bureaucracy, algorithmic alarms and the architecture of clinical encounters as by individual coping. For a condition that demands vigilance every waking hour, recognizing that the meaning of that vigilance changes across a lifetime may be the first step toward support that people actually find worth using.

Subject of Research: Life stage differences in diabetes distress among adults with type 1 diabetes explored through user-centered design workshops

Article Title: Understanding Diabetes Distress Across Adulthood in Type 1 Diabetes: A User‐Centered Design Study

Article References: Rayden, R., Crespo‐Ramos, G., Finnan, M., Hoogendoorn, C., Farchione, T., & Gonzalez, J. S. (2026). Understanding Diabetes Distress Across Adulthood in Type 1 Diabetes: A User‐Centered Design Study. Endocrinology, Diabetes & Metabolism, 9(5), Article e70331. https://doi.org/10.1002/edm2.70331

Image Credits: AI Generated

DOI: 10.1002/edm2.70331

Keywords: type 1 diabetes, diabetes distress, user-centered design, mental health, young adults, aging, cognitive-behavioral intervention, healthcare burden, insurance barriers, diabetes technology, qualitative research, psychosocial care

The study, conducted by Azélie Maurice of the Department of Anthropology at Southern Methodist University in Dallas, employed a qualitative design built around five semi-structured interviews with advocates recruited through nonprofit organizations. Rather than evaluating specific programs or prevention campaigns, as much of the earlier literature has done, the research set out to understand the roots and practices of eating disorder advocacy itself. The interviews were analyzed using reflexive thematic analysis, a flexible qualitative method in which themes are developed through the researcher’s active engagement with the data rather than through rigid, pre-set coding frameworks. To sharpen the interpretation, Maurice framed the analysis through two conceptual lenses: medicalization, which describes how conditions come to be defined and treated as medical problems, and neo-pluralist interest group theory, which examines how organized groups compete to influence policy within systems where power is unevenly distributed.

Three major themes emerged from the analysis, and together they sketch both the promise and the paradox of eating disorder advocacy. The first theme, stigma as both barrier and motivator, captures a central tension in advocates’ accounts. Stigma surrounding eating disorders, the participants explained, is not merely an unpleasant social attitude; it actively shapes who gets diagnosed, who gets treated, and whose suffering is taken seriously. Stereotypes that eating disorders affect only young, thin, white, affluent women continue to exclude men, people of color, older adults, and people in larger bodies from recognition and care. Advocates reported drawing directly on their own lived experience to challenge these stereotypes, using personal narratives to humanize the illness and push for more inclusive approaches to treatment. In this sense, stigma functioned paradoxically: it was the very obstacle that fueled their commitment, transforming personal pain into public purpose.

The second theme, navigating structural constraints, shifts the focus from social attitudes to institutional architecture. Participants described in striking detail how fragmented and uneven insurance systems restrict access to eating disorder treatment. In the United States, coverage for eating disorder care varies dramatically between insurers, between states, and even between individual policies. Advocates described patients being denied residential or intensive outpatient care, being discharged before recovery because benefits ran out, and being forced into financial ruin to continue treatment. These accounts align with longstanding critiques of managed care, in which utilization review and cost-containment mechanisms can override clinical judgment about the level of care a patient needs. For eating disorders, where early and sustained intervention strongly predicts recovery, such barriers are not merely inconvenient; they can be life-threatening.

The third theme, strategic repertoires, documents the practical toolkit that advocates have developed to work within and around these constraints. Participants described deploying personal storytelling as their most powerful instrument, since narratives of lived experience can shift public opinion in ways that statistics rarely do. Alongside storytelling, advocates reported using cost-based arguments, framing eating disorders not only as a humanitarian crisis but as an economic one, in which untreated illness generates far greater downstream costs than timely treatment. Education formed a third pillar, with advocates working to inform clinicians, schools, families, and policymakers about the realities of these illnesses. Finally, coalition-building emerged as a key strategy: by forming alliances with other advocacy organizations, professional bodies, and policymakers, advocates amplify voices that would otherwise be too small to be heard in the crowded arena of health policy.

Taken together, these themes reveal what Maurice describes as a fundamental paradox at the heart of eating disorder advocacy. The movement exists to challenge stigma and promote inclusion, yet it must operate inside a healthcare system shaped by profit-driven logics and chronic resource scarcity. Advocates are simultaneously critics of the system and participants in it, pressing for reform while negotiating with insurers, providers, and institutions whose incentives may run counter to comprehensive, long-term care. This paradox, the study suggests, is not a sign of failure but a structural condition of advocacy in the American context, where movements for health justice must often fight the system using the system’s own language of cost, evidence, and market logic.

One of the study’s most compelling insights concerns the dual role of lived experience. For advocates, personal history with an eating disorder serves simultaneously as a source of personal healing and as a form of political leverage. Telling one’s story publicly can consolidate recovery, give meaning to suffering, and connect the advocate to a community of others who understand. At the same time, that same story becomes a strategic asset in meetings with legislators, insurance companies, and media outlets, where the authenticity of lived experience can accomplish what clinical data alone cannot. This dual function, however, carries its own risks, including emotional exhaustion and the pressure to repeatedly perform one’s most vulnerable moments for institutional gain, a dynamic familiar from studies of advocacy in HIV/AIDS and breast cancer movements.

The comparison with those earlier movements is instructive. Advocacy for HIV/AIDS and breast cancer has received sustained scholarly attention and is widely credited with transforming research funding, drug approval pathways, and public awareness. Eating disorder advocacy, by contrast, has rarely been studied beyond program evaluation or prevention campaigns, leaving the field without a clear account of its own history, strategies, and internal tensions. By situating eating disorder advocacy within the broader landscape of health social movements, the new research helps correct that gap and provides a framework that future scholars can extend. The findings point to patterns that likely resonate internationally, even as they emphasize how distinctly the U.S. healthcare system and political environment shape what advocates can realistically achieve.

The study also opens several avenues for future research. Maurice suggests examining the relationships between advocates and healthcare practitioners, a dynamic that can range from productive partnership to friction over treatment philosophy and resource allocation. Another promising direction is the transition from patient to advocate, a process through which individuals convert recovery into activism and renegotiate their relationship with the illness. Finally, the evolving role of social media in shaping advocacy strategies deserves close attention, as digital platforms have lowered the barriers to storytelling and coalition-building while introducing new risks around misinformation, harassment, and the commercialization of recovery narratives.

For clinicians, policymakers, and the public, the message of this research is clear. Eating disorder advocacy is not a peripheral activity but a central force in the struggle for fair and effective care, and its effectiveness depends on conditions that society controls: insurance parity, inclusive diagnostic practices, and genuine recognition of who these illnesses affect. The advocates interviewed in this study demonstrate that lived experience, when organized and amplified, can contest stigma and demand accountability from powerful institutions. But their accounts also show that individual courage cannot substitute for structural change. As eating disorders continue to rise as a public health concern in the United States, the voices documented here offer both a roadmap and a warning: progress is possible, but only if the systems that ration care are themselves made the subject of reform.

Subject of Research: A qualitative reflexive thematic analysis of the motivations, strategies, and structural challenges of eating disorder advocacy in the United States.

Article Title: Contesting care, navigating paradoxes: a thematic reflexive analysis of eating disorders advocates voices

Article References: Maurice, A. (2026). Contesting care, navigating paradoxes: a thematic reflexive analysis of eating disorders advocates voices. Journal of Eating Disorders. https://doi.org/10.1186/s40337-025-01521-6

Image Credits: AI Generated

DOI: 10.1186/s40337-025-01521-6

Keywords: eating disorders, advocacy, lived experience, stigma, insurance barriers, reflexive thematic analysis, medicalization, health policy, mental health, qualitative research, nonprofit organizations, United States healthcare